首页|硝苯地平联合硫酸镁治疗妊娠期高血压疾病的临床效果及对子宫动脉血流的影响

硝苯地平联合硫酸镁治疗妊娠期高血压疾病的临床效果及对子宫动脉血流的影响

扫码查看
目的 探讨硝苯地平与硫酸镁联合治疗妊娠期高血压疾病(HDP)的临床效果及对子宫动脉血流的影响。方法 选取西华县人民医院2020年1月至2023年12月期间收治的80例HDP患者,以随机数字表法分成研究组(n=40)与对照组(n=40),对照组给予硝苯地平治疗,研究组给予硝苯地平联合硫酸镁治疗,比较两组临床疗效、血压水平、子宫动脉血流、母婴结局及不良反应。结果 研究组治疗有效率(92。50%)高于对照组(75。00%),差异有统计学意义(P<0。05);治疗后两组舒张压(DBP)、收缩压(SBP)水平降低,且研究组低于对照组,差异有统计学意义(P<0。05);治疗后两组阻力指数(RI)、搏动指数(PI)、收缩期峰值流速/舒张末期流速(S/D)降低,且研究组低于对照组,差异有统计学意义(P<0。05);研究组母婴不良结局发生率(40。00%)低于对照组(75。00%),差异有统计学意义(P<0。05);研究组不良反应发生率(62。50%)与对照组(67。50%)比较差异无统计学意义(P>0。05)。结论 硝苯地平与硫酸镁联合治疗HDP,能够提高临床疗效,降低血压水平,改善子宫动脉血流与母婴结局,不会额外增加不良反应。
Clinical Effects of Nifedipine Combined with Magnesium Sulfate in the Treatment of Hypertensive Disorders of Pregnancy and Its Impact on Uterine Artery Blood Flow
Objective To investigate the clinical effects of nifedipine combined with magnesium sulfate in the treatment of hypertensive disorders of pregnancy(HDP)and its impact on uterine artery blood flow.Methods Eighty patients with HDP treated at Xihua County People's Hospital from January 2020 to December 2023 were selected and randomly divided into a study group(n=40)and a control group(n=40)using a random number table.The control group was treated with nifedipine,while the study group was treated with nifedipine combined with magnesium sulfate.The clinical efficacy,blood pressure levels,uterine artery blood flow,maternal and infant outcomes,and adverse reactions were compared between the two groups.Results The treatment efficacy in the study group(92.50%)was higher than that in the control group(75.00%),with a statistically significant difference(P<0.05).After treatment,the diastolic blood pressure(DBP)and systolic blood pressure(SBP)levels in both groups decreased,with the study group showing lower levels than the control group,and the differences were statistically significant(P<0.05).After treatment,the resistance index(RI),pulsatility index(PI),and systolic/diastolic ratio(S/D)in both groups decreased,with the study group showing lower levels than the control group,and the differences were statistically significant(P<0.05).The incidence of adverse maternal and infant outcomes in the study group(40.00%)was lower than that in the control group(75.00%),with a statistically significant difference(P<0.05).The incidence of adverse reactions in the study group(62.50%)was not significantly different from that in the control group(67.50%)(P>0.05).Conclusion The combination of nifedipine and magnesium sulfate in the treatment of HDP can improve clinical efficacy,lower blood pressure levels,improve uterine artery blood flow and maternal and infant outcomes,without increasing adverse reactions.

hypertensive disorders of pregnancynifedipinemagnesium sulfateuterine artery blood flow

马纪红

展开 >

西华县人民医院 产科,河南 周口 466600

妊娠期高血压疾病 硝苯地平 硫酸镁 子宫动脉血流

2024

临床研究
西安交通大学

临床研究

影响因子:0.234
ISSN:2096-1278
年,卷(期):2024.32(8)